Symposium Preview: Meet the ALS/MND Plenary Speakers…Part 2
Related topics
The Motor Neurone Disease Association previewed plenary talks planned for the 34th International Symposium on ALS/MND. Topics include TDP-43 biology, RNA changes, clinical care, cognitive and behavioural symptoms, and how clinical trials could better group people with MND.
Why this matters
The programme highlights research questions that could inform future treatments, biomarkers, trial design and care guidance. However, these are planned presentations and do not yet show that any proposed approach benefits people with MND or changes current treatment.
Limitations and context
This is an organisational preview published before the symposium, not a primary research report or peer-reviewed study. It describes work and topics that speakers were expected to discuss, without reporting the results, study sizes or full methods. Any proposed therapies, biomarkers or care tools still require evidence from the underlying research and clinical studies.